EC: 1.17.1.4
xanthine dehydrogenase (xanthine:NAD+ oxidoreductase)
Pathways
| pathway id | name |
|---|---|
| BioCyc:HUMAN_PWY-5695 | urate biosynthesis/inosine 5'-phosphate degradation |
| BioCyc:META_SALVADEHYPOX-PWY | adenosine nucleotides degradation II |
| BioCyc:META_PWY-5044 | purine nucleotides degradation I (plants) |
| BioCyc:META_PWY-5695 | inosine 5'-phosphate degradation |
| BioCyc:META_PWY-6607 | guanosine nucleotides degradation I |
| BioCyc:MOUSE_URSIN-PWY | ureide biosynthesis |
| BioCyc:BSUB_PWY-6608 | guanosine nucleotides degradation III |
| BioCyc:BSUB_URSIN-PWY | ureide biosynthesis |
| BioCyc:ECOL316407_PWY-6608 | guanosine nucleotides degradation III |
| BioCyc:HUMAN_PWY-6875 | retinoate biosynthesis II |
| BioCyc:META_PWY-6596 | adenosine nucleotides degradation I |
| BioCyc:META_P165-PWY | superpathway of purines degradation in plants |
| BioCyc:ARA_PWY-6596 | adenosine nucleotides degradation I |
| BioCyc:MOUSE_PWY-6353 | purine nucleotides degradation II (aerobic) |
| BioCyc:BSUB_SALVADEHYPOX-PWY | adenosine nucleotides degradation II |
| BioCyc:HUMAN_PWY-6608 | guanosine nucleotides degradation |
| BioCyc:HUMAN_SALVADEHYPOX-PWY | adenosine nucleotides degradation |
| BioCyc:META_PWY-6608 | guanosine nucleotides degradation III |
| BioCyc:ECO_SALVADEHYPOX-PWY | adenosine nucleotides degradation II |
| BioCyc:ARA_PWY-6606 | guanosine nucleotides degradation II |
| BioCyc:ARA_PWY-6607 | guanosine nucleotides degradation I |
| BioCyc:MOUSE_PWY-5695 | urate biosynthesis/inosine 5'-phosphate degradation |
| BioCyc:MOUSE_SALVADEHYPOX-PWY | adenosine nucleotides degradation II |
| BioCyc:HUMAN_PWY-6353 | purine nucleotides degradation |
| BioCyc:META_PWY-6875 | retinoate biosynthesis II |
| BioCyc:META_PWY-6353 | purine nucleotides degradation II (aerobic) |
| BioCyc:META_PWY-6595 | superpathway of guanosine nucleotides degradation (plants) |
| BioCyc:META_PWY-6606 | guanosine nucleotides degradation II |
| BioCyc:ECO_PWY-6608 | guanosine nucleotides degradation III |
| BioCyc:MOUSE_PWY-6608 | guanosine nucleotides degradation III |
| BioCyc:BSUB_PWY-6353 | purine nucleotides degradation II (aerobic) |
| BioCyc:BSUB_PWY-5695 | inosine 5'-phosphate degradation |
| BioCyc:ECOL316407_SALVADEHYPOX-PWY | adenosine nucleotides degradation II |
| PathBank:SMP0002103 | Adenosine Nucleotides Degradation |
| Plant Reactome:R-OSA-5655149 | Nucleotide metabolism |
| Plant Reactome:R-OSA-2744345 | Metabolism and regulation |
| Plant Reactome:R-OSA-1119407 | ureide biogenesis |
| PlantCyc:ARA_P165-PWY | superpathway of purines degradation in plants |
| PlantCyc:PLANT_P165-PWY | superpathway of purines degradation in plants |
| PlantCyc:ARA_PWY-6596 | adenosine nucleotides degradation I |
| PlantCyc:PLANT_PWY-6596 | adenosine nucleotides degradation I |
| PlantCyc:PLANT_PWY-6607 | guanosine nucleotides degradation I |
| PlantCyc:ARA_PWY-6606 | guanosine nucleotides degradation II |
| PlantCyc:PLANT_PWY-6595 | superpathway of guanosine nucleotides degradation (plants) |
| PlantCyc:PLANT_PWY-5044 | purine nucleotides degradation I (plants) |
| PlantCyc:ARA_PWY-6607 | guanosine nucleotides degradation I |
| PlantCyc:ARA_PWY-5044 | purine nucleotides degradation I (plants) |
| PlantCyc:ARA_PWY-6595 | superpathway of guanosine nucleotides degradation (plants) |
| PlantCyc:PLANT_PWY-6606 | guanosine nucleotides degradation II |
| Reactome:R-RNO-9748784 | Drug ADME |
| Reactome:R-DDI-9748787 | Azathioprine ADME |
| Reactome:R-DME-9748787 | Azathioprine ADME |
| Reactome:R-HSA-9748787 | Azathioprine ADME |
| Reactome:R-MMU-9748784 | Drug ADME |
| Reactome:R-RNO-9748787 | Azathioprine ADME |
| Reactome:R-DDI-9748784 | Drug ADME |
| Reactome:R-DME-9748784 | Drug ADME |
| Reactome:R-HSA-9748784 | Drug ADME |
| Reactome:R-MMU-9748787 | Azathioprine ADME |
| Reactome:R-DDI-74259 | Purine catabolism |
| Reactome:R-DDI-196849 | Metabolism of water-soluble vitamins and cofactors |
| Reactome:R-GGA-1660598 | Metabolism |
| Reactome:R-HSA-8851680 | Butyrophilin (BTN) family interactions |
| Reactome:R-MMU-168256 | Immune System |
| Reactome:R-MMU-1430728 | Metabolism |
| Reactome:R-RNO-1280218 | Adaptive Immune System |
| Reactome:R-DDI-15869 | Nucleotide metabolism |
| Reactome:R-DDI-8956319 | Nucleotide catabolism |
| Reactome:R-DDI-196854 | Metabolism of vitamins and cofactors |
| Reactome:R-DME-1430728 | Metabolism |
| Reactome:R-DME-196849 | Metabolism of water-soluble vitamins and cofactors |
| Reactome:R-GGA-419470 | Nucleotide metabolism |
| Reactome:R-HSA-74259 | Purine catabolism |
| Reactome:R-MMU-8851680 | Butyrophilin (BTN) family interactions |
| Reactome:R-MMU-74259 | Purine catabolism |
| Reactome:R-RNO-74259 | Purine catabolism |
| Reactome:R-RNO-168256 | Immune System |
| Reactome:R-DME-15869 | Nucleotide metabolism |
| Reactome:R-DME-8956319 | Nucleotide catabolism |
| Reactome:R-DME-964975 | Vitamin B6 activation to pyridoxal phosphate |
| Reactome:R-HSA-168256 | Immune System |
| Reactome:R-MMU-1280218 | Adaptive Immune System |
| Reactome:R-RNO-1430728 | Metabolism |
| Reactome:R-DDI-1430728 | Metabolism |
| Reactome:R-DDI-964975 | Vitamin B6 activation to pyridoxal phosphate |
| Reactome:R-DME-74259 | Purine catabolism |
| Reactome:R-DME-196854 | Metabolism of vitamins and cofactors |
| Reactome:R-GGA-419474 | Purine metabolism |
| Reactome:R-GGA-421178 | Urate synthesis |
| Reactome:R-HSA-1430728 | Metabolism |
| Reactome:R-HSA-15869 | Nucleotide metabolism |
| Reactome:R-HSA-8956319 | Nucleotide catabolism |
| Reactome:R-HSA-1280218 | Adaptive Immune System |
| Reactome:R-MMU-15869 | Nucleotide metabolism |
| Reactome:R-MMU-8956319 | Nucleotide catabolism |
| Reactome:R-RNO-15869 | Nucleotide metabolism |
| Reactome:R-RNO-8956319 | Nucleotide catabolism |
| Reactome:R-RNO-8851680 | Butyrophilin (BTN) family interactions |
| WikiPathways:WP4792 | Purine metabolism |
| WikiPathways:WP5355 | Metabolic Epileptic Disorders |
| WikiPathways:WP4224 | Purine metabolism and related disorders |
| WikiPathways:WP4507 | Molybdenum cofactor (Moco) biosynthesis |
| PathBank:SMP0120448 | Adenosine Deaminase Deficiency |
| PathBank:SMP0120452 | AICA-Ribosiduria |
| PathBank:SMP0120508 | Lesch-Nyhan Syndrome (LNS) |
| PathBank:SMP0120532 | Molybdenum Cofactor Deficiency |
| PathBank:SMP0120536 | Purine Nucleoside Phosphorylase Deficiency |
| PathBank:SMP0120577 | Xanthinuria Type I |
| PathBank:SMP0120601 | Mitochondrial DNA Depletion Syndrome |
| PathBank:SMP0000028 | Caffeine Metabolism |
| PathBank:SMP0000167 | Adenylosuccinate Lyase Deficiency |
| PathBank:SMP0000220 | Xanthine Dehydrogenase Deficiency (Xanthinuria) |
| PathBank:SMP0000512 | Xanthinuria Type I |
| PathBank:SMP0000536 | Mitochondrial DNA Depletion Syndrome-3 |
| PathBank:SMP0000609 | Mercaptopurine Metabolism Pathway |
| PathBank:SMP0063475 | Caffeine Metabolism |
| PathBank:SMP0063604 | Caffeine Metabolism |
| PathBank:SMP0063668 | Purine Metabolism |
| PathBank:SMP0120600 | Adenine Phosphoribosyltransferase Deficiency (APRT) |
| PathBank:SMP0000050 | Purine Metabolism |
| PathBank:SMP0000144 | Adenosine Deaminase Deficiency |
| PathBank:SMP0000203 | Molybdenum Cofactor Deficiency |
| PathBank:SMP0000428 | Mercaptopurine Action Pathway |
| PathBank:SMP0000535 | Adenine Phosphoribosyltransferase Deficiency (APRT) |
| PathBank:SMP0120449 | Adenylosuccinate Lyase Deficiency |
| PathBank:SMP0120489 | Gout or Kelley-Seegmiller Syndrome |
| PathBank:SMP0120497 | Xanthine Dehydrogenase Deficiency (Xanthinuria) |
| PathBank:SMP0120578 | Xanthinuria Type II |
| PathBank:SMP0120602 | Myoadenylate Deaminase Deficiency |
| PathBank:SMP0000365 | Gout or Kelley-Seegmiller Syndrome |
| PathBank:SMP0000210 | Purine Nucleoside Phosphorylase Deficiency |
| PathBank:SMP0000430 | Thioguanine Action Pathway |
| PathBank:SMP0000513 | Xanthinuria Type II |
| PathBank:SMP0000537 | Myoadenylate Deaminase Deficiency |
| PathBank:SMP0000650 | Doxorubicin Metabolism Pathway |
| PathBank:SMP0012052 | AMP Degradation (Hypoxanthine Route) |
| PathBank:SMP0000364 | Lesch-Nyhan Syndrome (LNS) |
| PathBank:SMP0000168 | AICA-Ribosiduria |
| PathBank:SMP0000427 | Azathioprine Action Pathway |
| PathBank:SMP0063777 | Nitric Oxide Signaling Pathway |